A novel transient cell line to enable high yield and scalable rAAV production with low encapsidated host cell DNA

  • <<
  • >>

BlueskyReddit

Obtain efficient and scalable production of rAAVs by transient transfection across multiple serotypes with low levels of encapsidated hcDNA.

Access Now

    Please fill out the information below to access the selected content. If you are already registered, and this information will be filled out for you.
  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.